Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine.
about
High yield production process for Shigella outer membrane particlesCharacterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection.A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis).A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsAn O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBAlterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri.Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosisConstruction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.Factors affecting virulence of Shigella flexneri: defective methionine synthesis in an Escherichia coli-Shigella hybrid.Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella sppProgress and pitfalls in Shigella vaccine research.Persistence of an Escherichia coli-Shigella flexneri hybrid in the intestinal tract of Macaca mulatta.The demonstration and function of antibodies in the gastrointestinal tractImmunochemistry of Shigella flexneri O-antigens: a study of structural and genetic aspects of the biosynthesis of cell-surface antigens.Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmidRole of antigen form in development of mucosal immunoglobin A response to Shigella flexneri Antigens.Genetic Transfer of Shigella flexneri Antigens to Escherichia coli K-12.Identification of Two Widely Separated Loci Conferring Nicotinic Acid Dependence on Wild-Type Shigella flexneri 2a.Contribution to the study of live streptomycin-dependent Salmonella vaccines: the problem of reversion to a virulent form.Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA).
P2860
Q28728768-1A8EDA1E-8094-4F0C-8B54-2026E80BB20AQ33608118-B96A3EA1-85EE-430D-B684-7B2980166519Q33676706-F178B0C2-76F1-4ECD-9BB7-D76C7FD4BF26Q33678906-EC418CDF-6A43-4823-B2C8-4BE158780923Q34138990-B77F5D0B-359A-4E36-90ED-3A0171AB0F18Q35202321-D6A8095F-5B67-4E10-B34A-13AE0682EB9AQ35924773-2EC444F1-67CF-41B6-8559-E2A6EFDDA15FQ36347107-B5166400-43F3-4AB4-8767-B5CCF2A37118Q36365336-BAD6FB85-57B2-4285-8B73-FFBF85F0348BQ36431701-177B6355-519F-4BE1-819D-8BF13C5629DFQ36833963-9CF01C13-F7B3-41EA-8341-92C86D1C5666Q36844719-022090E8-DE63-40D5-A468-F8A13537F6DBQ36989971-185901F3-AA4F-4B00-9A55-7338205F107FQ37010733-256261EB-3A02-4D2F-A94D-5BDD60C61461Q37105553-3801CA16-388F-4E38-A098-F9774AC05F49Q37157779-794DE2FE-7791-4A63-AEBF-C750D8FA4EC3Q39896117-9BD6ECEA-9198-48FA-9BEB-27178C8383FAQ40000509-AA0614AA-045F-475F-85A8-A3EFB4EEA171Q40168452-C480914C-0B5F-42CE-BD33-EADD962093E9Q40210819-31AC8DFE-746A-4545-B6FB-796FD8048DFDQ40211202-33AD1E7A-1801-4F8F-8234-F7619974305DQ40598013-E62EBEFC-AA0B-4D04-B279-C62B6C3FF572Q40614472-771F23C3-3AE4-478C-A854-888512A85A8FQ40884062-F0547DAA-4A0E-4F6C-A557-2BB6C5603D37Q40885433-ABA42A49-B20B-4BC5-9E50-82A92CD57801Q40894609-842B1B28-5C62-42BB-B4DD-81B005E2D704Q43056566-14A499FC-48E4-4C5F-B825-3B5FDBBAA05C
P2860
Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1966
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protection of monkeys against ...... polyvalent dysentery vaccine.
@en
Protection of monkeys against ...... polyvalent dysentery vaccine.
@nl
type
label
Protection of monkeys against ...... polyvalent dysentery vaccine.
@en
Protection of monkeys against ...... polyvalent dysentery vaccine.
@nl
prefLabel
Protection of monkeys against ...... polyvalent dysentery vaccine.
@en
Protection of monkeys against ...... polyvalent dysentery vaccine.
@nl
P2093
P2860
P1476
Protection of monkeys against ...... l polyvalent dysentery vaccine
@en
P2093
P2860
P407
P577
1966-07-01T00:00:00Z